Clinical Trial Update: Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose systemic methotrexate in patients with metastatic breast cancer and leptomeningeal metastasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Metastatic Breast Cancer, Leptomeningeal Disease | Phase 2 | Status: RECRUITING